RT Book, Section
A1 Dezube, Bruce J.
A2 Boyiadzis, Michael M.
A2 Frame, James N.
A2 Kohler, David R.
A2 Fojo, Tito
SR Print(0)
ID 1160299663
T1 HIV-Related Malignancies
T2 Hematology-Oncology Therapy, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071637893
LK hemonc.mhmedical.com/content.aspx?aid=1160299663
RD 2024/04/19
AB Epidemiology  of  KSTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiology  of  KSIncidence/100,000United  StatesMales:2.1Females:0.11AfricaMales:39.3Females:21.8Stage  at  Presentation  in  HAART  Era  (Based  on  ACTG✫  Modified  TIS  Staging)Poor  risk:25%Good  risk:75%✫ACTG:  AIDS  Clinical  Trials  GroupDeaths  caused  by  AIDS  since  advent  of  HAART  have  decreased  by  more  than  50%  Nasti  G  et  al.  J  Clin  Oncol  2003;21:2876–2882